Department of Molecular Microbiology and Immunology, Brown University, Providence, R.I. 02912, USA.
Yale University School of Medicine, Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, 300 Cedar Street (TAC S441), New Haven, CT 06520, USA.
Sci Rep. 2016 May 20;6:26299. doi: 10.1038/srep26299.
Chi3l1 is induced by a variety of cancers where it portends a poor prognosis and plays a key role in the generation of metastasis. However, the mechanisms that Chi3l1 uses to mediate these responses and the pathways that control Chi3l1-induced tumor responses are poorly understood. We characterized the mechanisms that Chi3l1 uses to foster tumor progression and the ability of the RIG-like helicase (RLH) innate immune response to control Chi3l1 elaboration and pulmonary metastasis. Here we demonstrate that RLH activation inhibits tumor induction of Chi3l1 and the expression of receptor IL-13Rα2 and pulmonary metastasis while restoring NK cell accumulation and activation, augmenting the expression of IFN-α/β, chemerin and its receptor ChemR23, p-cofilin, LIMK2 and PTEN and inhibiting BRAF and NLRX1 in a MAVS-dependent manner. These studies demonstrate that Chi3l1 is a multifaceted immune stimulator of tumor progression and metastasis whose elaboration and tissue effects are abrogated by RLH innate immune responses.
Chi3l1 被多种癌症诱导,预示着预后不良,并在转移的产生中发挥关键作用。然而,Chi3l1 用于介导这些反应的机制以及控制 Chi3l1 诱导的肿瘤反应的途径还知之甚少。我们描述了 Chi3l1 促进肿瘤进展的机制,以及 RIG 样螺旋酶(RLH)先天免疫反应控制 Chi3l1 表达和肺转移的能力。在这里,我们证明 RLH 激活抑制肿瘤诱导的 Chi3l1 表达和受体 IL-13Rα2 的表达,以及肺转移,同时恢复 NK 细胞的积累和激活,增强 IFN-α/β、趋化素及其受体 ChemR23、p-cofilin、LIMK2 和 PTEN 的表达,并以 MAVS 依赖的方式抑制 BRAF 和 NLRX1。这些研究表明,Chi3l1 是肿瘤进展和转移的多方面免疫刺激物,其表达和组织效应被 RLH 先天免疫反应所阻断。